Vidal will succeed Stéphane Lavallée, who will now serve as the non-executive chair of the surgical robotic guidance company.
“Through his excellent management of key strategic development programs within eCential Robotics, Clément has proven himself to be not only an amazing leader, but a visionary with a solid understanding of the surgical robotics market,” Lavallée said in a news release. “I am most confident that Clément will succeed in taking the company to the next level, with the same passion and commitment to innovation that has always been our hallmark.”
Prior to joining the company, Vidal was CEO of surgical robotics company Endocontrol. He has over 20 years of experience in the pharmaceutical and medical device industry.
“I am honored to take on the role of CEO at such an exciting time for the company,” said Vidal. “The team recently demonstrated its ability to successfully partner with MedTech companies, as well as commercialize our proprietary robotics system by signing a supply contract with a major healthcare group in the United States.”
Under Vidal’s leadership, eCential Robotics will enhance the company’s product portfolio roadmap, develop its commercial activities in the U.S. and partner internationally with implant manufacturers, tech companies and research labs.
eCential Robotics works with leading surgeons to develop an open, modular and scalable 2D/3D imaging, navigation and robotic guidance system for spine surgery. The system has received FDA clearance and the company is now gearing up to develop more commercial activities in the U.S.
